{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T01:06:01Z","timestamp":1783559161973,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T00:00:00Z","timestamp":1691366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T00:00:00Z","timestamp":1691366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Des Moines University of Osteopathic Medicine","award":["IOER 112-3749"],"award-info":[{"award-number":["IOER 112-3749"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-023-02077-8","type":"journal-article","created":{"date-parts":[[2023,8,6]],"date-time":"2023-08-06T23:09:07Z","timestamp":1691363347000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Artichoke as a melanoma growth inhibitor"],"prefix":"10.1007","volume":"40","author":[{"given":"Annette M.","family":"Mathew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuliang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian J.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trenton G.","family":"Mayberry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Lequio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emerson","family":"Fajardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaping","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Wakefield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9107-7374","authenticated-orcid":false,"given":"Yujiang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,7]]},"reference":[{"issue":"1","key":"2077_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348. https:\/\/doi.org\/10.3322\/caac.21763.","journal-title":"CA Cancer J Clin"},{"key":"2077_CR2","unstructured":"American Cancer Society. Melanoma skin cancer statistics. American Cancer Society. https:\/\/www.cancer.org\/cancer\/melanoma-skin-cancer\/about\/key-statistics.html. Accessed 31 Dec 2022."},{"key":"2077_CR3","unstructured":"American Cancer Society. Melanoma skin cancer risk factors: melanoma risk factors. American Cancer Society. https:\/\/www.cancer.org\/cancer\/melanoma-skin-cancer\/causes-risks-prevention\/risk-factors.html. Accessed 31 Dec 2022."},{"key":"2077_CR4","unstructured":"American Cancer Society. Preventing melanoma: can melanoma be prevented? American Cancer Society. https:\/\/www.cancer.org\/cancer\/melanoma-skin-cancer\/causes-risks-prevention\/prevention.html. Accessed 31 Dec 2022."},{"issue":"3","key":"2077_CR5","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s40257-016-0186-4","volume":"17","author":"M Singh","year":"2016","unstructured":"Singh M, Alavi A, Wong R, Akita S. Radiodermatitis: a review of our current understanding. Am J Clin Dermatol. 2016;17(3):277\u201392. https:\/\/doi.org\/10.1007\/s40257-016-0186-4.","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"2077_CR6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/ptr.6213","volume":"33","author":"S Salekzamani","year":"2019","unstructured":"Salekzamani S, Ebrahimi-Mameghani M, Rezazadeh K. The antioxidant activity of artichoke (Cynara scolymus): a systematic review and meta-analysis of animal studies. Phytother Res. 2019;33(1):55\u201371. https:\/\/doi.org\/10.1002\/ptr.6213.","journal-title":"Phytother Res"},{"issue":"4","key":"2077_CR7","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s11130-015-0503-8","volume":"70","author":"M Ben Salem","year":"2015","unstructured":"Ben Salem M, Affes H, Ksouda K, Dhouibi R, Sahnoun Z, Hammami S, Zeghal KM. Pharmacological studies of artichoke leaf extract and their health benefits. Plant Foods Hum Nutr. 2015;70(4):441\u201353. https:\/\/doi.org\/10.1007\/s11130-015-0503-8.","journal-title":"Plant Foods Hum Nutr"},{"issue":"137","key":"2077_CR8","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.phrs.2018.10.007","volume":"2018","author":"HO Santos","year":"2018","unstructured":"Santos HO, Bueno AA, Mota JF. The effect of artichoke on lipid profile: a review of possible mechanisms of action. Pharmacol Res. 2018;2018(137):170\u20138. https:\/\/doi.org\/10.1016\/j.phrs.2018.10.007 (Epub 9 Oct 2018).","journal-title":"Pharmacol Res"},{"issue":"6","key":"2077_CR9","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1111\/j.1349-7006.2012.02272.x","volume":"103","author":"Y Fang","year":"2012","unstructured":"Fang Y, DeMarco VG, Nicholl MB. Resveratrol enhances radiation sensitivity in prostate cancer by inhibiting cell proliferation and promoting cell senescence and apoptosis. Cancer Sci. 2012;103(6):1090\u20138. https:\/\/doi.org\/10.1111\/j.1349-7006.2012.02272.x. (Epub 15 April 2012).","journal-title":"Cancer Sci"},{"key":"2077_CR10","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1182\/blood-2006-02-003988","volume":"109","author":"A Bhardwaj","year":"2007","unstructured":"Bhardwaj A, Sethi G. Vadhan-Raj S et al Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-\u049dB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells. Blood. 2007;109:2293\u2013302.","journal-title":"Blood"},{"key":"2077_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/carcin\/bgh220","volume":"26","author":"JL Su","year":"2005","unstructured":"Su JL, Lin MT. Hong CC et al Resveratrol induces FasL-related apoptosis through Cdc42 activation of ASK\/JNK-dependent signaling pathway in human leukemia HL-60 cells. Carcinogenesis. 2005;26:1\u201310.","journal-title":"Carcinogenesis"},{"key":"2077_CR12","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/sj.bjc.6604938","volume":"100","author":"R Diaz","year":"2009","unstructured":"Diaz R, Nguewa PA. Diaz-Gonzalez JA et al The novel Akt inhibitor Palomid 529 (P529) enhances the effect of radiotherapy in prostate cancer. Br J Cancer. 2009;100:932\u201340.","journal-title":"Br J Cancer"},{"key":"2077_CR13","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1146\/annurev.pharmtox.39.1.295","volume":"39","author":"DG Johnson","year":"1999","unstructured":"Johnson DG, Walker CL. Cyclins and cell cycle checkpoints. Annu Rev Pharmacol Toxicol. 1999;39:295\u2013312. https:\/\/doi.org\/10.1146\/annurev.pharmtox.39.1.295.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"2","key":"2077_CR14","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/s0962-8924(02)00043-0","volume":"13","author":"O Coqueret","year":"2003","unstructured":"Coqueret O. New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment? Trends Cell Biol. 2003;13(2):65\u201370. https:\/\/doi.org\/10.1016\/s0962-8924(02)00043-0.","journal-title":"Trends Cell Biol"},{"issue":"7","key":"2077_CR15","doi-asserted-by":"publisher","first-page":"jcs223826","DOI":"10.1242\/jcs.223826","volume":"132","author":"SP Wheatley","year":"2019","unstructured":"Wheatley SP, Altieri DC. Survivin at a glance. J Cell Sci. 2019;132(7):jcs223826. https:\/\/doi.org\/10.1242\/jcs.223826.","journal-title":"J Cell Sci"},{"issue":"69","key":"2077_CR16","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.dnarep.2018.07.008","volume":"2018","author":"M Abbastabar","year":"2018","unstructured":"Abbastabar M, Kheyrollah M, Azizian K, Bagherlou N, Tehrani SS, Maniati M, Karimian A. Multiple functions of p27 in cell cycle, apoptosis, epigenetic modification and transcriptional regulation for the control of cell growth: a double-edged sword protein. DNA Repair (Amst). 2018;2018(69):63\u201372. https:\/\/doi.org\/10.1016\/j.dnarep.2018.07.008. (Epub 20 July 2018).","journal-title":"DNA Repair (Amst)"},{"issue":"42","key":"2077_CR17","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.dnarep.2016.04.008","volume":"2016","author":"A Karimian","year":"2016","unstructured":"Karimian A, Ahmadi Y, Yousefi B. Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage. DNA Repair (Amst). 2016;2016(42):63\u201371. https:\/\/doi.org\/10.1016\/j.dnarep.2016.04.008. (Epub 22 April 2016).","journal-title":"DNA Repair (Amst)"},{"issue":"8","key":"2077_CR18","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.3390\/cancers11081178","volume":"11","author":"B Shamloo","year":"2019","unstructured":"Shamloo B, Usluer S. p21 in cancer research. Cancers (Basel). 2019;11(8):1178. https:\/\/doi.org\/10.3390\/cancers11081178.","journal-title":"Cancers (Basel)"},{"issue":"8","key":"2077_CR19","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1096\/fasebj.13.8.773","volume":"13","author":"R Donnellan","year":"1999","unstructured":"Donnellan R, Chetty R. Cyclin E in human cancers. FASEB J. 1999;13(8):773\u201380. https:\/\/doi.org\/10.1096\/fasebj.13.8.773.","journal-title":"FASEB J"},{"issue":"22","key":"2077_CR20","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1101\/gad.1256504","volume":"18","author":"CJ Sherr","year":"2004","unstructured":"Sherr CJ, Roberts JM. Living with or without cyclins and cyclin-dependent kinases. Genes Dev. 2004;18(22):2699\u2013711. https:\/\/doi.org\/10.1101\/gad.1256504.","journal-title":"Genes Dev"},{"issue":"14","key":"2077_CR21","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.18632\/oncotarget.26515","volume":"10","author":"K Kollmann","year":"2019","unstructured":"Kollmann K, Briand C, Bellutti F, Schicher N, Blunder S, Zojer M, Hoeller C. The interplay of CDK4 and CDK6 in melanoma. Oncotarget. 2019;10(14):1346\u201359. https:\/\/doi.org\/10.18632\/oncotarget.26515.","journal-title":"Oncotarget"},{"key":"2077_CR22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.18632\/genesandcancer.221","volume":"13","author":"SJ Baker","year":"2022","unstructured":"Baker SJ, Poulikakos PI, Irie HY, Parekh S, Reddy EP. CDK4: a master regulator of the cell cycle and its role in cancer. Genes Cancer. 2022;13:21\u201345. https:\/\/doi.org\/10.18632\/genesandcancer.221.","journal-title":"Genes Cancer"},{"issue":"1","key":"2077_CR23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/ng0994-15","volume":"8","author":"CJ Hussussian","year":"1994","unstructured":"Hussussian CJ, Struewing JP, Goldstein AM, et al. Germline p16 mutations in familial melanoma. Nat Genet. 1994;8(1):15\u201321. https:\/\/doi.org\/10.1038\/ng0994-15.","journal-title":"Nat Genet"},{"issue":"1","key":"2077_CR24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/ng0994-22","volume":"8","author":"A Kamb","year":"1994","unstructured":"Kamb A, Shattuck-Eidens D, Eeles R, et al. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat Genet. 1994;8(1):23\u20136. https:\/\/doi.org\/10.1038\/ng0994-22.","journal-title":"Nat Genet"},{"issue":"20","key":"2077_CR25","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1038\/sj.onc.1206461","volume":"22","author":"E Sharpless","year":"2003","unstructured":"Sharpless E, Chin L. The INK4a\/ARF locus and melanoma. Oncogene. 2003;22(20):3092\u20138. https:\/\/doi.org\/10.1038\/sj.onc.1206461.","journal-title":"Oncogene"},{"issue":"1","key":"2077_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/jmedgenet-2015-103150","volume":"53","author":"J Read","year":"2016","unstructured":"Read J, Wadt KAW, Hayward NK. Melanoma genetics. J Med Genet. 2016;53(1):1\u201314. https:\/\/doi.org\/10.1136\/jmedgenet-2015-103150.","journal-title":"J Med Genet"},{"issue":"23","key":"2077_CR27","first-page":"5475","volume":"56","author":"J Bartkova","year":"1996","unstructured":"Bartkova J, Lukas J, Guldberg P, et al. The p16-cyclin D\/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis. Cancer Res. 1996;56(23):5475\u201383.","journal-title":"Cancer Res"},{"issue":"4","key":"2077_CR28","doi-asserted-by":"publisher","first-page":"389","DOI":"10.4103\/0971-5916.159250","volume":"141","author":"PK Jaiswal","year":"2015","unstructured":"Jaiswal PK, Goel A, Mittal RD. Survivin: a molecular biomarker in cancer. Indian J Med Res. 2015;141(4):389\u201397. https:\/\/doi.org\/10.4103\/0971-5916.159250.","journal-title":"Indian J Med Res"},{"issue":"3","key":"2077_CR29","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s12032-021-01465-2","volume":"38","author":"L Kou","year":"2021","unstructured":"Kou L, Zhu Z, Redington C, Bai Q, Wakefield M, Lequio M, Fang Y. Potential use of kiwifruit extract for treatment of melanoma. Med Oncol. 2021;38(3):25. https:\/\/doi.org\/10.1007\/s12032-021-01465-2.","journal-title":"Med Oncol"},{"issue":"2","key":"2077_CR30","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.jss.2013.02.037","volume":"183","author":"Y Fang","year":"2013","unstructured":"Fang Y, Bradley MJ, Cook KM, Herrick EJ, Nicholl MB. A potential role for resveratrol as a radiation sensitizer for melanoma treatment. J Surg Res. 2013;183(2):645\u201353. doi: https:\/\/doi.org\/10.1016\/j.jss.2013.02.037 (Epub 14 March 2013).","journal-title":"J Surg Res"},{"issue":"5","key":"2077_CR31","first-page":"1799","volume":"33","author":"Y Fang","year":"2013","unstructured":"Fang Y, Moore BJ, Bai Q, Cook KM, Herrick EJ, Nicholl MB. Hydrogen peroxide enhances radiation-induced apoptosis and inhibition of melanoma cell proliferation. Anticancer Res. 2013;33(5):1799\u2013807.","journal-title":"Anticancer Res"},{"issue":"4","key":"2077_CR32","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1615\/CritRevEukaryotGeneExpr.2020028454","volume":"30","author":"B Ahmed","year":"2020","unstructured":"Ahmed B, Qadir MI, Ghafoor S. Malignant melanoma: skin cancer-diagnosis, prevention, and treatment. Crit Rev Eukaryot Gene Expr. 2020;30(4):291\u20137. https:\/\/doi.org\/10.1615\/CritRevEukaryotGeneExpr.2020028454.","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"2077_CR33","unstructured":"Shi W. Radiation therapy for melanoma. In: Ward WH, Farma JM, editors. Cutaneous melanoma: etiology and therapy. Codon Publications; 2017. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK481863\/. Accessed 4 July 2020."},{"key":"2077_CR34","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.ctrv.2018.08.01","volume":"70","author":"MA McKean","year":"2018","unstructured":"McKean MA, Amaria RN. Multidisciplinary treatment strategies in high-risk resectable melanoma: role of adjuvant and neoadjuvant therapy. Cancer Treat Rev. 2018;70:144\u201353. https:\/\/doi.org\/10.1016\/j.ctrv.2018.08.01.","journal-title":"Cancer Treat Rev"},{"issue":"2","key":"2077_CR35","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.tranon.2015.12.003","volume":"9","author":"MM Kim","year":"2016","unstructured":"Kim MM, Parmar H, Cao Y, et al. Whole brain radiotherapy and RRx-001: two partial responses in radioresistant melanoma brain metastases from a Phase I\/II clinical trial. Transl Oncol. 2016;9(2):108\u201313. https:\/\/doi.org\/10.1016\/j.tranon.2015.12.003.","journal-title":"Transl Oncol"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-023-02077-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-023-02077-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-023-02077-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T23:46:52Z","timestamp":1693439212000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-023-02077-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,7]]},"references-count":35,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["2077"],"URL":"https:\/\/doi.org\/10.1007\/s12032-023-02077-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2887392\/v1","asserted-by":"object"}]},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,7]]},"assertion":[{"value":"2 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"262"}}